≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other and unspecified mental retardation

DOID EFO Endpoint Browser PheWeb

F5_OTHRET

mental retardation: ['Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual is mentally retarded. IQ scores between 70 and 79 are in the borderline mentally retarded range. Scores below 67 are in the retarded range. (Joynt, Clinical Neurology, 1992, Ch55, p28)']

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — F78, F79
  • Hospital discharge: ICD-9 — 3199
  • Hospital discharge: ICD-8 — 315
  • Cause of death: ICD-10 — F78, F79
  • Cause of death: ICD-9 — 3199
  • Cause of death: ICD-8 — 315

2 out of 7 registries used, show all original rules.

587

4. Check minimum number of events

None

587

5. Include endpoints

None

587

6. Filter based on genotype QC (FinnGen only)

587

Control definitions (FinnGen only)

Control exclude
F5_MENTRET

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 16429 6793 9614
Only index persons 12801 5334 7467
Unadjusted period prevalence (%)
Whole population 0.24 0.19 0.27
Only index persons 0.25 0.20 0.29
Median age at first event (years)
Whole population 7.92 9.25 6.90
Only index persons 9.82 11.70 8.48

-FinnGen-

Key figures

All Female Male
Number of individuals 587 266 321
Unadjusted period prevalence (%) 0.12 0.09 0.14
Median age at first event (years) 10.49 13.30 8.16

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
534
Matched controls
5330
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
1186.5
285.4
254
*
F79.9
ICD-10 Finland
Unspecified mental retardation, without mention of impairment of behaviour
1207.8
104.9
99
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
15.5
96.9
170
156
N03AG01
ATC
valproic acid; systemic, rectal
14.9
95.8
171
163
P85
ICPC
Mental retardation
129.4
91.3
96
9
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
513.1
90.0
87
*
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
8.6
73.2
180
299
F79.1
ICD-10 Finland
Unspecified mental retardation, significant impairment of behaviour requiring attention or treatment
+∞
69.3
65
*
N05AX08
ATC
risperidone; systemic
10.7
66.1
137
166
G40.9
ICD-10 Finland
Epilepsy, unspecified
16.6
65.2
108
80
N05BA09
ATC
clobazam; oral
31.8
63.2
84
31
113
Kela drug reimbursment
Anxiety disorders associated with mental retardation
+∞
61.6
58
*
183
Kela drug reimbursment
Lamotrigin and topiramate
32.8
56.2
74
26
N05BA01
ATC
diazepam; systemic, rectal
7.3
55.9
149
267
F83
ICD-10 Finland
Mixed specific developmental disorders
13.4
55.8
101
91
3199A
ICD-9 Finland
Unspecified mental retardation[MUU ÄLYLLINEN KEHITYSVAMMAISUUS,EI KÄYTTÄYTYMIHÄIRI]
+∞
55.1
52
*
F71.0
ICD-10 Finland
Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour
583.3
54.5
53
*
N03AX14
ATC
levetiracetam; systemic
16.1
54.1
90
66
F78.0
ICD-10 Finland
Other mental retardation, with the statement of no, or minimal, impairment of behaviour
+∞
54.0
51
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
18.6
53.5
84
53
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
71.9
51.3
58
9
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
+∞
48.7
46
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
8.4
48.4
114
166
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
7.2
47.2
125
217
31599
ICD-8 Finland
Unspecified mental retardation, Other and unspecified
+∞
46.5
44
*
N03AG04
ATC
vigabatrin; oral
167.1
44.5
46
*
N03AX09
ATC
lamotrigine; oral
9.1
44.2
98
128
R62.0
ICD-10 Finland
Delayed milestone
9.3
43.2
94
119
F70.9
ICD-10 Finland
Mild mental retardation, Without mention of impairment of behaviour
+∞
42.2
40
*
N05CD08
ATC
midazolam; nasal, systemic
12.0
40.8
77
74
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
5.7
39.9
127
276
N03AX11
ATC
topiramate; oral
14.5
39.0
67
52
N05AA02
ATC
levomepromazine; systemic
10.8
36.8
73
77
181
Kela drug reimbursment
Retigabine and vigabatrin
135.8
36.2
38
*
F79
ICD-10 Finland
Unspecified mental retardation
346.9
33.2
33
*
F72.0
ICD-10 Finland
Severe mental retardation, with the statement of no, or minimal, impairment of behaviour
+∞
32.6
31
*
N05AH03
ATC
olanzapine; systemic
6.5
32.2
89
159
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.3
31.0
102
226
A06AD11
ATC
lactulose; oral
5.7
30.6
94
192
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.6
29.7
160
563
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
14.4
29.3
50
38
N03AF01
ATC
carbamazepine; oral, rectal
9.6
28.8
60
69
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.1
28.8
126
372
G40.89
ICD-10 Finland
Other epilepsy
38.4
28.7
36
10
XA800
NOMESCO Finland
Neuropsychological investigation
5.1
28.6
98
226
EBA15
NOMESCO Finland
Extraction of large number of teeth
7.1
28.1
72
115
F29
ICD-10 Finland
Unspecified nonorganic psychosis
7.6
27.6
67
99
Z2446
NOMESCO Finland
Social worker
3.7
27.0
137
458
RL140
NOMESCO Finland
NA
16.0
26.5
43
29
N05BA06
ATC
lorazepam; systemic, sublingual
9.2
26.3
56
67
N03AF02
ATC
oxcarbazepine; oral
6.9
26.1
68
111
F20.9
ICD-10 Finland
Schizophrenia, unspecified
12.1
25.6
47
42
F71.1
ICD-10 Finland
Moderate mental retardation, significant impairment of behaviour requiring attention or treatment
+∞
25.2
24
*
Z31.5
ICD-10 Finland
Genetic counselling
5.3
25.2
81
173
N05AC02
ATC
thioridazine; oral
14.6
24.9
42
31
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.5
24.5
94
242
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
11.9
24.3
45
41
Z01.1
ICD-10 Finland
Examination of ears and hearing
3.3
23.7
144
543
A28
ICPC
Limited function/disability NOS
4.3
23.1
92
245
L28
ICPC
Limited function/disability (L)
4.4
22.6
87
224
N05AH04
ATC
quetiapine; oral
3.3
22.4
127
455
RT490
NOMESCO Finland
NA
25.2
22.4
31
13
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.8
21.8
177
807
N03AE01
ATC
clonazepam; systemic
6.9
21.6
55
87
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
24.3
21.5
30
13
Z2445
NOMESCO Finland
Psychologist
3.8
21.4
99
301
G80.9
ICD-10 Finland
Cerebral palsy, unspecified
62.5
21.0
24
*
N05AB03
ATC
perphenazine; systemic, rectal
9.6
21.0
43
48
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
19.2
20.6
31
17
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.5
20.4
77
194
RT274
NOMESCO Finland
NA
59.8
20.0
23
*
H50.30
ICD-10 Finland
Intermittent esotropy
9.5
20.0
41
46
Z3229
NOMESCO Finland
Other healthcare associate professional
3.6
19.7
98
315
H52.2
ICD-10 Finland
Astigmatism
7.2
19.2
47
70
F78.1
ICD-10 Finland
Other mental retardation, significant impairment of behaviour requiring attention or treatment
+∞
18.8
18
*
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
12.0
18.7
34
30
F84.0
ICD-10 Finland
Childhood autism
39.9
18.7
23
6
N03AF03
ATC
rufinamide; oral
103.5
18.7
20
*
F71.9
ICD-10 Finland
Moderate mental retardation, without mention of impairment of behaviour
196.3
18.6
19
*
SPAT1262
SPAT
Handing over of treatment supplies
3.3
18.4
105
372
RT150
NOMESCO Finland
NA
10.9
18.4
35
34
M41.4
ICD-10 Finland
Neuromuscular scoliosis
45.6
18.4
22
5
M79.0
ICD-10 Finland
Rheumatism, unspecified
12.0
18.2
33
29
N05AH02
ATC
clozapine; systemic
8.4
18.1
40
51
N03AB02
ATC
phenytoin; systemic
38.1
17.7
22
6
N05AF03
ATC
chlorprothixene; systemic
7.8
17.3
40
55
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
12.1
17.2
31
27
Z3226
NOMESCO Finland
Physiotherapist
2.5
17.2
160
770
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
10.0
17.1
34
36
RS222
NOMESCO Finland
NA
9.3
16.9
35
40
SAA03
NOMESCO Finland
Extended examination of mouth
2.2
16.9
285
1829
7834D
ICD-9 Finland
Symptoms concerning nutrition, metabolism and development, Lack of expected normal physiological development[LAPSEN NORMAALIN KEHITTYMISEN HIDASTUMINEN]
+∞
16.7
16
*
N04AA02
ATC
biperiden; systemic
10.5
16.6
32
32
SPAT1229
SPAT
Assessment of need for aid
5.7
16.6
48
90
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.7
16.5
75
223
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
10.2
16.4
32
33
RT190
NOMESCO Finland
NA
25.4
16.1
22
9
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.7
16.0
128
562
P72
ICPC
Schizophrenia
10.9
15.9
30
29
78159
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Laesio loquendi alia sive NUD
34.5
15.8
20
6
3459X
ICD-9 Finland
Epilepsy, unspecified
87.6
15.6
17
*
N05AD01
ATC
haloperidol; systemic
8.1
15.6
35
46
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
39.2
15.5
19
5
R1260
NOMESCO Finland
Evaluation of communicative skills
8.7
15.5
33
40
R11
ICD-10 Finland
Nausea and vomiting
3.4
15.4
80
265
G40.10
ICD-10 Finland
Simple partial seizures
16.7
15.4
24
15
N06AB04
ATC
citalopram; systemic
2.8
14.9
106
434
RL130
NOMESCO Finland
NA
8.8
14.7
31
37
F71
ICD-10 Finland
Moderate mental retardation
+∞
14.6
14
*
31199
ICD-8 Finland
Mild mental retardation, Other and unspecified
+∞
14.6
14
*
SDA02
NOMESCO Finland
Parodonthologic therapy
2.2
14.6
200
1145
31099
ICD-8 Finland
Borderline mental retardation, Other and unspecified
82.3
14.6
16
*
TJD20
NOMESCO Finland
Change of gastrostomy tube
10.5
14.6
28
28
Q99.8
ICD-10 Finland
Other specified chromosome abnormalities
15.9
14.5
23
15
N03AX15
ATC
zonisamide; oral
19.8
14.3
21
11
199
Kela drug reimbursment
Rufinamide
77.0
13.6
15
*
3170A
ICD-9 Finland
Mild mental retardation[LIEVÄ ÄLYLL.KEHITYSVAMMAISUUS,EI KÄYTÄYTYM.HÄIRIÖTÄ]
+∞
13.6
13
*
3199B
ICD-9 Finland
Unspecified mental retardation[MUU ÄLYLLINEN KEHITYSVAMMAISUUS JA KÄYTTÄYTYMIHÄIRI]
+∞
13.6
13
*
N88
ICPC
Epilepsy
16.7
13.5
21
13
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
16.7
13.5
21
13
ADB00
NOMESCO Finland
Implantation of vagus nerve stimulating device
143.2
13.5
14
*
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
26.5
13.4
18
7
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.8
13.3
95
388
N05AX12
ATC
aripiprazole; systemic
4.3
13.2
50
126
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
13.2
200
1185
JDB10
NOMESCO Finland
Percutaneous gastrostomy
11.3
13.1
24
22
G40.39
ICD-10 Finland
Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures
11.3
13.1
24
22
R4110
NOMESCO Finland
Physiotherapy
2.2
12.8
162
888
K03.66
ICD-10 Finland
Tooth plaque
2.8
12.8
87
343
N03AX18
ATC
lacosamide; systemic
12.7
12.7
22
18
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
3.0
12.6
79
294
3046
Kela drug reimbursment
NA
+∞
12.5
12
*
N03AX17
ATC
stiripentol; oral
+∞
12.5
12
*
V628A
ICD-9 Finland
Other psychosocial circumstances, Other psychological or physical stress, not elsewhere classified
+∞
12.5
12
*
3153A
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[KIELENKEHITYKSEN ERITYISVAIKEUS]
132.8
12.5
13
*
N05AC01
ATC
periciazine; systemic
132.8
12.5
13
*
H50.0
ICD-10 Finland
Convergent concomitant strabismus
8.3
12.5
27
34
G03DC03
ATC
lynestrenol; oral
8.3
12.5
27
34
SPAT1234
SPAT
Support of social functional capacity
6.2
12.4
33
56
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.6
12.3
97
419
N05BA04
ATC
oxazepam; oral
2.4
12.2
118
567
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
5.4
12.2
36
70
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.6
12.0
98
430
SAA02
NOMESCO Finland
Basic examination of mouth
2.0
12.0
397
3136
N06AA09
ATC
amitriptyline; systemic
4.0
12.0
48
128
34599
ICD-8 Finland
Epilepsy, Other and unspecified
47.7
11.9
14
*
H47.7
ICD-10 Finland
Disorder of visual pathways, unspecified
47.7
11.9
14
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.8
11.8
50
140
G40.00
ICD-10 Finland
Benign childhood epilepsy with centrotemporal EEG spikes
16.8
11.7
18
11
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
30.7
11.7
15
5
T90
ICPC
Diabetes non-insulin dependent
2.7
11.6
84
343
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
8.9
11.6
24
28
EBA00
NOMESCO Finland
Extraction of tooth
2.0
11.6
209
1314
N05AA01
ATC
chlorpromazine; systemic, rectal
14.0
11.5
19
14
F78.9
ICD-10 Finland
Other mental retardation, without mention of impairment of behaviour
+∞
11.5
11
*
F72.1
ICD-10 Finland
Severe mental retardation, significant impairment of behaviour requiring attention or treatment
+∞
11.5
11
*
OAB43
SPAT
NA
0.2
11.4
14
585
A10BA02
ATC
metformin; oral
2.5
11.4
97
437
U04
ICPC
Incontinence urine
5.9
11.3
31
55
ZXE00
NOMESCO Finland
One hour or less
1.9
11.3
235
1550
L17
ICPC
Foot/toe symptom/complaint
2.2
11.2
136
725
WYA30
SPAT
NA
13.1
11.2
19
15
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
8.3
11.2
24
30
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.1
11.1
64
227
Q04.8
ICD-10 Finland
Other specified congenital malformations of brain
44.2
11.0
13
*
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.2
10.9
9
483
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
10.7
174
1044
N05AF05
ATC
zuclopenthixol; systemic
13.2
10.7
18
14
G80.0
ICD-10 Finland
Spastic quadriplegic cerebral palsy
61.1
10.7
12
*
M03BX01
ATC
baclofen; systemic
11.5
10.6
19
17
P99
ICPC
Psychological disorders other
5.8
10.6
29
52
H50.31
ICD-10 Finland
Intermittent exotropia
6.1
10.6
28
48
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.6
10.5
78
325
G80.3
ICD-10 Finland
Dyskinetic cerebral palsy
111.9
10.4
11
*
3451A
ICD-9 Finland
Epilepsy, Generalised convulsive epilepsy
+∞
10.4
10
*
3170B
ICD-9 Finland
Mild mental retardation[LIEVÄ ÄLYLL.KEHITYSVAMMAISUUS,JOSSA KÄYTÄYTYM.HÄIRI]
+∞
10.4
10
*
31509
ICD-8 Finland
Unspecified mental retardation, Following infections and intoxications, Unspecified
+∞
10.4
10
*
3153X
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[PUHEEN KEHITYKSEN ERITYISVAIKEUS]
33.2
10.4
13
*
K02.1
ICD-10 Finland
Caries of dentine
1.8
10.4
319
2387
NAG53
NOMESCO Finland
Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea
19.2
10.3
15
8
RS142
NOMESCO Finland
NA
23.9
10.3
14
6
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.2
10.3
14
555
G41.9
ICD-10 Finland
Status epilepticus, unspecified
13.4
10.2
17
13
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.9
10.1
65
247
4122
FHL
Tympanostomy (tympanic tube)
6.5
9.9
25
40
3812A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media
7.2
9.9
23
33
AA1AD
NOMESCO Finland
CT of head and brain
2.4
9.8
87
398
N05CD07
ATC
temazepam; oral
3.4
9.8
47
147
N03AA02
ATC
phenobarbital; systemic
55.9
9.7
11
*
Q93.5
ICD-10 Finland
Other deletions of part of a chromosome
55.9
9.7
11
*
F22.9
ICD-10 Finland
Persistent delusional disorder, unspecified
55.9
9.7
11
*
H50.1
ICD-10 Finland
Divergent concomitant strabismus
9.3
9.6
19
21
78020
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Convulsions
10.3
9.6
18
18
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
9.5
210
1394
AA10D
NOMESCO Finland
NA
101.6
9.4
10
*
4451
FHL
Guitar cutting
3.8
9.4
39
108
7803A
ICD-9 Finland
General symptoms, Convulsions
8.3
9.4
20
25
F73.0
ICD-10 Finland
Profound mental retardation, with the statement of no, or minimal, impairment of behaviour
+∞
9.4
9
*
F70
ICD-10 Finland
Mild mental retardation
+∞
9.4
9
*
3AX01
NOMESCO Finland
NA
22.1
9.4
13
6
UDC00
NOMESCO Finland
Ear microscopy
2.9
9.4
58
216
F22.0
ICD-10 Finland
Delusional disorder
9.7
9.3
18
19
Z2221
NOMESCO Finland
Medical doctor
1.9
9.3
159
963
R32
ICD-10 Finland
Unspecified urinary incontinence
6.2
9.3
24
40
C03CA01
ATC
furosemide; systemic
2.5
9.3
76
332
RT160
NOMESCO Finland
NA
7.9
9.2
20
26
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
9.1
101
513
K59.0
ICD-10 Finland
Constipation
3.7
9.1
39
111
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.6
9.1
67
276
F20.5
ICD-10 Finland
Residual schizophrenia
15.9
9.1
14
9
Z93.1
ICD-10 Finland
Gastrostomy status
37.3
9.0
11
*
K02.9
ICD-10 Finland
Dental caries, unspecified
6.3
9.0
23
38
H52.0
ICD-10 Finland
Hypermetropia
3.9
9.0
36
97
G91.1
ICD-10 Finland
Obstructive hydrocephalus
19.0
9.0
13
7
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
24.4
8.9
12
5
R60.0
ICD-10 Finland
Localized oedema
3.2
8.9
46
152
K59.09
ICD-10 Finland
Constipation, unspecified
3.0
8.8
50
175
R50.9
ICD-10 Finland
Fever, unspecified
2.1
8.8
114
620
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
4.8
8.7
28
61
G80.8
ICD-10 Finland
Other cerebral palsy
50.7
8.7
10
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
8.6
109
585
P28
ICPC
Limited function/disability (P)
16.6
8.6
13
8
Z01.2
ICD-10 Finland
Dental examination
1.7
8.6
262
1908
RS312
NOMESCO Finland
NA
28.0
8.5
11
*
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
28.0
8.5
11
*
F20.8
ICD-10 Finland
Other schizophrenia
28.0
8.5
11
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.3
8.4
81
384
Q04.3
ICD-10 Finland
Other reduction deformities of brain
91.3
8.4
9
*
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.6
8.4
60
244
RF311
NOMESCO Finland
NA
+∞
8.3
8
*
31500
ICD-8 Finland
Unspecified mental retardation, Following infections and intoxications, Post infectionem praenatalem
+∞
8.3
8
*
F72.9
ICD-10 Finland
Severe mental retardation, without mention of impairment of behaviour
+∞
8.3
8
*
H47.6
ICD-10 Finland
Disorders of visual cortex
+∞
8.3
8
*
G40
ICD-10 Finland
Epilepsy
11.0
8.3
15
14
N05AD03
ATC
melperone; systemic
9.6
8.3
16
17
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.5
8.2
64
272
H13
ICPC
Plugged feeling ear
2.3
8.2
75
349
Z3231
NOMESCO Finland
Registered nurse
1.8
8.1
184
1216
3454A
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]
33.8
8.1
10
*
5210A
ICD-9 Finland
Diseases of hard tissues of teeth, Dental caries
33.8
8.1
10
*
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
9.1
8.1
16
18
30180
ICD-8 Finland
Personality disorders, Immatura
22.4
8.0
11
5
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.8
8.0
32
87
RS211
NOMESCO Finland
NA
6.7
7.9
19
29
R4130
NOMESCO Finland
Speech therapy
3.6
7.9
34
98
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.3
7.9
76
362
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
6.2
7.9
20
33
DFF20
NOMESCO Finland
Audiometry for children
4.1
7.9
29
73
WYA20
NOMESCO Finland
Home visit
7.1
7.8
18
26
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.3
7.8
37
116
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
3.3
7.8
37
116
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
15.3
7.7
12
8
Q89.7
ICD-10 Finland
Multiple congenital malformations, not elsewhere classified
15.3
7.7
12
8
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.8
7.7
164
1060
Z02.7
ICD-10 Finland
Issue of medical certificate
3.5
7.7
35
106
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
18.6
7.6
11
6
N03AD01
ATC
ethosuximide; oral
18.6
7.6
11
6
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
7.6
185
1247
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.4
7.6
26
657
M03BX02
ATC
tizanidine; oral
0.6
7.6
120
1818
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
7.6
114
653
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
25.4
7.6
10
*
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
3.5
7.6
34
102
R13
ICD-10 Finland
Dysphagia
4.0
7.6
29
76
R4120
NOMESCO Finland
Occupational therapy
2.7
7.6
51
200
XX4AW
NOMESCO Finland
NA
4.5
7.5
25
57
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.5
7.5
60
259
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
4.7
7.5
24
53
H61.2
ICD-10 Finland
Impacted cerumen
3.4
7.4
35
109
Q02
ICD-10 Finland
Microcephaly
81.0
7.4
8
*
Z50.5
ICD-10 Finland
Speech therapy
2.9
7.4
44
161
Z39.2
ICD-10 Finland
Routine postpartum follow-up
0.1
7.4
*
283
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
2.1
7.4
83
425
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
8.5
7.3
15
18
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
3.1
7.3
39
133
N03AX22
ATC
perampanel; oral
11.0
7.3
13
12
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.0
7.3
94
506
31109
ICD-8 Finland
Mild mental retardation, Following infections and intoxications, Unspecified
+∞
7.3
7
*
R45.1
ICD-10 Finland
Restlessness and agitation
+∞
7.3
7
*
G40.0
ICD-10 Finland
Localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset
+∞
7.3
7
*
31299
ICD-8 Finland
Moderate mental retardation, Other and unspecified
+∞
7.3
7
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.0
7.3
101
561
S01.3
ICD-10 Finland
Open wound of ear
16.0
7.2
11
7
SPAT1301
SPAT
No procedures
1.8
7.2
157
1018
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
7.2
141
886
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
7.2
109
624
R33
ICD-10 Finland
Retention of urine
3.7
7.2
30
85
3159X
ICD-9 Finland
Specific delays in development, Unspecified delay in development
20.3
7.1
10
5
F21
ICD-10 Finland
Schizotypal disorder
8.1
7.1
15
19
ZXA10
NOMESCO Finland
Bilateral
2.0
7.1
100
559
U07
ICPC
Urine symptom/complaint other
3.3
7.1
34
108
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
7.0
96
532
SCF02
NOMESCO Finland
Preventive oral care by dental hygienist
3.0
7.0
40
142
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.0
7.0
88
470
KMAK
NOMESCO Finland
NA
1.7
6.9
217
1562
R4190
NOMESCO Finland
Nutritional therapy
2.3
6.9
64
297
RS314
NOMESCO Finland
NA
14.0
6.9
11
8
F20
ICD-10 Finland
Schizophrenia
14.0
6.9
11
8
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.8
6.9
42
157
-31
ICPC
Medical examin/health eval partial
2.9
6.9
41
151
F82
ICD-10 Finland
Specific developmental disorder of motor function
3.7
6.9
28
78
H54.7
ICD-10 Finland
Unspecified visual loss
8.4
6.9
14
17
F61.0
ICD-10 Finland
Mixed personality disorders
5.1
6.9
20
40
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.7
6.8
47
187
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.7
6.8
47
187
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.2
6.8
34
111
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
11.1
6.8
12
11
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
0.2
6.8
6
306
R53
ICD-10 Finland
Malaise and fatigue
2.0
6.8
87
470
H51.9
ICD-10 Finland
Disorder of binocular movement, unspecified
40.5
6.8
8
*
R5210
NOMESCO Finland
Assessment of the improvements needed in the living environment
40.5
6.8
8
*
M01AB05
ATC
diclofenac; systemic, rectal
0.6
6.8
130
1885
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.6
6.7
48
197
WX402
NOMESCO Finland
General anaesthesia
1.9
6.7
115
687
A10BH01
ATC
sitagliptin; oral
3.3
6.7
32
102
R62.8
ICD-10 Finland
Other lack of expected normal physiological development
5.6
6.6
18
33
NF1DA
NOMESCO Finland
X-ray of hips
6.0
6.6
17
29
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
12.4
6.6
11
9
H26.02
ICD-10 Finland
Presenil cataract
7.0
6.5
15
22
N05AN01
ATC
lithium; oral
4.6
6.5
21
47
F99
ICD-10 Finland
Mental disorder, not otherwise specified
5.4
6.5
18
34
M79.7
ICD-10 Finland
Fibromyalgia
5.8
6.5
17
30
P91.02
ICD-10 Finland
Neonatal hypoxic-ischaemic encephalopathy, severe
70.5
6.4
7
*
Q85.1
ICD-10 Finland
Tuberous sclerosis
70.5
6.4
7
*
2988A
ICD-9 Finland
Other nonorganic psychoses, Other and unspecified reactive psychosis
70.5
6.4
7
*
A03FA02
ATC
cisapride; oral, rectal
3.2
6.4
32
105
T82
ICPC
Obesity
3.5
6.4
28
83
NFK30
NOMESCO Finland
Angulation, rotation or displacement osteotomy of femur
14.5
6.4
10
7
Q90.9
ICD-10 Finland
Down syndrome, unspecified
14.5
6.4
10
7
K05.18
ICD-10 Finland
Chronic gingivitis
3.0
6.4
36
126
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.8
6.4
122
757
F60.9
ICD-10 Finland
Personality disorder, unspecified
6.7
6.4
15
23
K07.24
ICD-10 Finland
Open bite
4.1
6.3
23
58
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.6
6.3
47
194
S22
ICPC
Nail symptom/complaint
3.0
6.3
36
127
103
Kela drug reimbursment
Diabetes, insulin-treated
1.9
6.3
94
533
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
4.7
6.3
20
44
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.1
6.3
33
112
RS230
NOMESCO Finland
NA
9.4
6.3
12
13
N05CD02
ATC
nitrazepam; oral
9.4
6.3
12
13
RT130
NOMESCO Finland
NA
18.2
6.3
9
5
Q93.8
ICD-10 Finland
Other deletions from the autosomes
18.2
6.3
9
5
WX730
NOMESCO Finland
Conventional respirator
4.9
6.3
19
40
NEK20
NOMESCO Finland
Fenestration or forage of bone of pelvis
+∞
6.3
6
*
G40.59
ICD-10 Finland
Other special epileptic syndromes
+∞
6.3
6
*
3180A
ICD-9 Finland
Other specified mental retardation, Moderate mental retardation[KESKIVAIKEA ÄLYLL KEHITYSVAMMAISUUS,EI KÄYTÄYT.HÄIR]
+∞
6.3
6
*
AAF50
NOMESCO Finland
Third ventriculostomy
+∞
6.3
6
*
N03AX24
ATC
cannabidiol; oral
+∞
6.3
6
*
31550
ICD-8 Finland
Unspecified mental retardation, With chromosomal abnormalities, Morbus Down (mongolismi)
+∞
6.3
6
*
WX110
NOMESCO Finland
Local anesthesy
1.6
6.3
356
2955
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.1
6.3
73
378
H60.9
ICD-10 Finland
Otitis externa, unspecified
2.6
6.2
44
179
SPAT1364
SPAT
Health check-up performed during second study year in students of upper secondary schools, vocational schools etc.
0.1
6.2
*
230
R1250
NOMESCO Finland
Evaluation of functional capability
4.6
6.2
20
45
TJF80
NOMESCO Finland
Ostomy education
6.4
6.2
15
24
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
6.2
108
650
N99
ICPC
Neurological disease other
7.8
6.1
13
17
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
6.1
117
727
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.5
6.1
46
195
N28
ICPC
Limited function/disability (N)
6.8
6.1
14
21
4121
FHL
Tympanic puncture or parasentosis in general anesthesia or operating room
6.8
6.1
14
21
H53.0
ICD-10 Finland
Amblyopia ex anopsia
4.2
6.1
21
51
N06AX03
ATC
mianserin; oral
3.9
6.0
23
61
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
3.2
6.0
29
93

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3009466) Valproate [Moles/volume] in Serum or Plasma
132
87
19.27
156.08
5.9
5.0
umol/l
442.5
366.3
4.46
124
81
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
26
11
24.67
36.18
3.3
2.6
umol/l
22.8
15.5
1.26
26
11
(3026008) Bacteria identified in Urine by Culture
208
935
2.89
31.11
4.0
2.5
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
25
20
13.00
25.60
1.1
1.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
201
968
2.64
25.46
4.7
4.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
142
612
2.74
22.07
2.1
2.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
331
2144
2.25
20.19
13.2
11.5
mmol/l
1.2
1.2
0.90
317
2024
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
345
2273
2.25
20.18
13.0
11.0
mmol/l
1.2
1.2
0.93
308
2045
(3024561) Albumin [Mass/volume] in Serum or Plasma
262
1619
2.12
17.15
4.7
7.2
g/l
36.0
36.9
1.61
248
1553
(3023183) Ammonium ion [Moles/volume] in Plasma
57
169
3.63
16.59
2.1
4.1
umol/l
36.3
37.2
0.12
51
156
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
109
470
2.62
16.57
2.1
2.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
108
468
2.60
16.23
2.1
1.9
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
65
215
3.27
15.96
1.4
1.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
364
2586
2.07
15.88
7.8
7.0
mmol/l
6.5
6.3
0.76
349
2420
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
194
1103
2.13
15.48
2.8
3.0
u/l
50.7
57.3
1.62
186
1041
(21494755) Public health laboratory ask at order entry panel
9
552
0.15
13.59
1.1
1.3
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
100
459
2.42
13.16
7.1
13.2
mmol/l
1.6
1.4
0.55
90
418
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
289
1981
1.90
12.99
6.4
7.9
umol/l
16.3
18.6
0.42
273
1866
(3032080) INR in Blood by Coagulation assay
203
1268
1.92
11.87
11.4
6.3
inr
1.2
1.2
0.51
57
356
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
240
1594
1.85
11.52
4.5
4.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
162
946
1.98
11.50
3.3
3.3
e6/l
6.9
5.7
0.49
143
834
(3031040) Bacteria [#/volume] in Urine by Automated count
358
2700
1.83
11.23
6.1
3.9
e6/l
231.8
137.6
—
6
37
(3023103) Potassium [Moles/volume] in Serum or Plasma
524
4511
2.50
11.14
22.8
14.2
mmol/l
4.0
4.0
3.92
513
4385
(3012095) Magnesium [Moles/volume] in Serum or Plasma
134
740
2.05
11.08
4.0
10.0
mmol/l
0.8
0.8
0.29
129
706
(3002582) Erythrocytes [#/volume] in Urine
221
1446
1.85
11.02
4.7
4.1
e6/l
58.1
34.1
0.29
175
1112
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
390
3029
1.85
11.02
6.9
6.8
u/l
110.0
103.0
0.91
369
2858
(3019550) Sodium [Moles/volume] in Serum or Plasma
523
4506
2.47
10.97
23.1
14.3
mmol/l
139.4
139.5
0.43
514
4397
(3002032) Base excess in Venous blood by calculation
150
869
1.97
10.82
5.8
9.9
mmol/l
1.7
1.3
0.89
121
672
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
259
1794
1.79
10.60
3.2
3.1
nmol/l
78.2
72.3
2.35
245
1672
(3018418) pH of Serum or Plasma
174
1067
1.90
10.56
4.6
4.1
ph
7.4
7.4
1.08
39
185
(3026782) Osmolality of Urine
154
907
1.94
10.56
3.6
3.1
mosm/kgh2o
525.0
580.9
1.92
132
785
(3009343) pH of Capillary blood
146
848
1.96
10.41
15.7
9.6
ph
7.4
7.4
—
6
33
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
145
841
1.96
10.38
15.8
9.6
mmol/l
1.1
1.0
0.17
117
593
(3018095) Leukocytes [#/volume] in Urine
245
1685
1.78
10.16
5.9
4.8
e6/l
162.3
52.6
0.97
175
1168
(3007853) Bacteria identified in Skin by Aerobe culture
115
619
2.07
10.12
2.0
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
76
1460
0.45
9.88
3.1
2.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
81
387
2.27
9.62
4.7
7.0
ng/l
60.2
59.4
0.03
75
369
(3003458) Phosphate [Moles/volume] in Serum or Plasma
149
893
1.89
9.59
6.3
10.6
mmol/l
1.2
1.3
1.29
143
848
(3022217) INR in Platelet poor plasma by Coagulation assay
65
284
2.45
9.44
10.9
15.0
inr
1.2
1.3
0.30
12
51
(3021447) Carbon dioxide [Partial pressure] in Venous blood
146
875
1.89
9.37
5.9
9.8
kpa
5.9
5.8
1.22
140
860
(3015377) Calcium [Moles/volume] in Serum or Plasma
191
1249
1.78
9.22
2.8
3.2
mmol/l
2.4
2.4
0.38
175
1129
(3012501) Base excess in Blood by calculation
29
81
3.71
9.21
5.0
6.4
mmol/l
2.4
2.4
0.01
22
53
(3022313) Gas panel - Capillary blood
128
742
1.93
9.06
14.4
9.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
136
806
1.89
9.00
8.4
11.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
137
819
1.88
8.81
5.5
9.7
kpa
5.5
5.2
0.47
132
806
(1616796) Gas panel - Central venous blood
31
94
3.42
8.73
4.0
4.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
118
678
1.93
8.54
3.4
3.9
ng/l
596.2
791.9
0.30
75
466
(36304419) Bacteria [Presence] in Urine
196
1338
1.70
7.90
4.7
3.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
50
212
2.48
7.75
2.2
1.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
79
416
2.04
7.29
1.6
1.6
nmol/l
1047.0
1240.2
1.18
63
320
(3030467) Casts [#/volume] in Urine by Automated count
193
1337
1.66
7.25
4.9
3.8
e6/l
0.3
0.3
0.09
150
1004
(3011397) Hemoglobin [Presence] in Urine by Test strip
162
1081
1.69
6.98
4.0
3.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
208
1482
1.62
6.93
4.2
4.6
u/l
37.7
34.9
0.22
201
1420
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
171
1171
1.65
6.62
1.9
1.8
pmol/l
94.0
98.2
0.56
91
604
(3020682) Albumin/Creatinine [Ratio] in Urine
129
823
1.73
6.51
4.9
4.2
mg/mmol
13.3
29.3
0.34
87
548
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
40
167
2.50
6.42
1.9
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
40
167
2.50
6.42
1.9
1.4
—
—
—
0
0
(3032641) Amino acids panel - Urine
10
15
6.76
6.32
1.0
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
39
831
0.43
6.29
2.3
2.3
—
—
—
0
0
(3009410) PHENobarbital [Moles/volume] in Serum or Plasma
9
5
18.24
6.28
12.6
9.2
umol/l
104.7
105.4
—
9
5
(3009508) Creatinine [Moles/volume] in Urine
174
1212
1.62
6.24
4.5
4.1
mmol/l
6.4
8.2
5.54
160
1081
(3013115) Eosinophils [#/volume] in Blood
345
2809
1.55
6.22
8.1
9.6
e9/l
0.2
0.2
1.43
303
2412
(3006315) Basophils [#/volume] in Blood
336
2728
1.54
6.08
7.5
8.7
e9/l
0.0
0.0
0.08
291
2297
(3040151) Glucose [Moles/volume] in Capillary blood
20
58
3.53
6.05
5.2
8.9
mmol/l
7.5
6.1
0.61
15
51
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
91
536
1.82
6.00
1.7
1.6
pmol/l
447.4
460.7
0.15
71
465
(3013336) Amino acids [Identifier] in Serum or Plasma
17
45
3.86
5.84
1.1
2.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
36
150
2.49
5.82
2.1
3.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
398
3376
1.55
5.73
4.2
3.7
pmol/l
14.5
14.5
0.03
372
3133
(42870588) Differential panel, method unspecified - Blood
261
2025
1.52
5.71
6.5
9.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
334
2731
1.52
5.68
7.4
8.7
e9/l
0.6
0.6
1.94
289
2296
(3012516) Albumin [Mass/volume] in Urine
122
794
1.68
5.66
3.9
3.4
mg/l
65.1
268.2
1.02
87
544
(3008898) HLA-B27 [Presence]
5
258
0.19
5.57
1.2
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
52
260
2.10
5.51
1.9
1.8
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
264
2065
1.50
5.50
4.6
3.3
estimate
0.0
0.0
0.00
52
347
(3019198) Lymphocytes [#/volume] in Blood
340
2809
1.50
5.37
7.3
8.7
e9/l
2.3
2.2
0.81
300
2430
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
38
772
0.46
5.37
2.2
2.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
81
478
1.80
5.30
5.4
10.6
mmol/l
105.5
104.8
0.31
81
471
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
116
760
1.65
5.23
3.3
4.8
ng/l
1743.8
1171.4
0.20
98
628
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
86
520
1.77
5.19
2.4
2.5
mmol/l
2.4
2.4
0.16
76
449
(3003396) Base excess in Arterial blood by calculation
66
369
1.89
5.12
9.7
11.9
mmol/l
0.9
0.6
0.26
57
297
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
29
116
2.58
5.11
2.2
2.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
358
3006
1.49
5.10
11.7
11.5
e9/l
4.2
3.7
2.70
315
2541
(3019060) Gas panel - Arterial blood
36
160
2.33
5.08
4.9
7.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
22
76
2.97
5.08
3.5
3.4
%
16.6
17.1
0.24
13
47
(3020717) Zinc [Moles/volume] in Serum or Plasma
18
56
3.28
4.92
2.9
2.5
umol/l
12.4
17.5
1.20
18
56
(3021601) Nitrite [Presence] in Urine by Test strip
260
2060
1.47
4.92
6.2
4.8
estimate
0.0
0.0
0.00
53
364
(3006504) Eosinophils/100 leukocytes in Blood
317
2615
1.46
4.83
7.3
9.0
%
2.5
3.2
5.62
301
2500
(40758558) Short blood count panel - Blood
206
1563
1.49
4.82
7.7
9.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
518
4747
1.77
4.80
11.4
9.8
u/l
27.2
28.5
0.74
508
4615
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
123
836
1.60
4.76
4.4
3.5
e6/l
2.5
1.5
0.68
67
472
(3019069) Monocytes/100 leukocytes in Blood
318
2630
1.45
4.75
7.8
9.2
%
8.2
8.4
0.49
306
2527
(3009261) Glucose [Presence] in Urine by Test strip
261
2086
1.45
4.64
4.5
3.3
estimate
0.0
0.0
0.50
50
341
(3022096) Basophils/100 leukocytes in Blood
310
2563
1.44
4.57
7.2
9.1
%
0.6
0.7
1.41
297
2457
(3015736) pH of Urine
212
1641
1.46
4.41
4.3
3.2
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
63
369
1.79
4.24
9.3
11.9
kpa
5.7
5.3
1.42
63
349
(3027801) Oxygen [Partial pressure] in Arterial blood
63
369
1.79
4.24
9.3
11.9
kpa
12.9
14.3
0.90
63
350
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
268
0.29
4.22
1.1
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
26
109
2.45
4.20
2.2
2.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
305
2540
1.42
4.18
10.1
11.1
e9/l
0.0
0.0
0.06
248
1970
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
152
1112
1.49
4.17
3.9
2.9
ng/l
32.2
33.7
0.04
101
630
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
376
4216
0.70
4.07
3.4
3.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
445
3979
1.49
4.07
5.0
4.2
mu/l
2.0
2.2
0.30
420
3720
(3018010) Neutrophils/100 leukocytes in Blood
319
2686
1.41
4.06
7.4
8.7
%
51.9
51.5
0.19
301
2587
(3037467) Urinalysis macro (dipstick) panel - Urine
344
2935
1.41
4.05
5.5
4.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
33
157
2.17
4.01
6.9
10.2
mmol/l
25.3
24.3
0.60
33
142
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
118
1621
0.66
3.96
1.9
1.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
88
577
1.62
3.92
2.2
2.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
447
4848
0.67
3.92
24.5
15.0
%
38.2
40.0
3.91
326
4184
(3013512) EKG study
117
820
1.53
3.92
3.8
3.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
322
2732
1.39
3.83
7.7
8.9
%
32.6
33.2
0.33
306
2631
(3029937) Albumin [Presence] in Urine by Test strip
138
1011
1.48
3.72
4.9
3.6
estimate
0.0
0.0
0.50
51
354
(3051651) Icteric interference index of Serum or Plasma
17
61
2.84
3.71
1.8
4.5
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
51
292
1.82
3.71
7.9
11.2
g/l
125.7
124.4
0.15
51
278
(3017181) Myelocytes/100 leukocytes in Blood
56
330
1.77
3.71
4.9
5.4
%
0.9
0.7
0.11
21
113
(40761536) Microorganisms panel - Urine sediment
56
331
1.76
3.67
4.5
3.4
—
—
—
0
0
(3049233) Organic acids panel - Urine
11
30
3.72
3.65
1.5
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
32
604
0.50
3.63
1.7
1.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
143
1061
1.46
3.61
2.2
3.1
mg/l
3.0
2.8
0.67
122
947
(3051611) Lipemic interference index of Serum or Plasma
19
74
2.62
3.58
2.1
4.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
118
848
1.49
3.49
4.3
3.3
e6/l
1.1
0.7
0.95
61
484
(3025159) Blasts/100 leukocytes in Blood
51
299
1.77
3.44
5.1
5.7
%
0.0
0.1
0.82
16
89
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
13
341
0.37
3.42
1.2
1.3
u/ml
0.2
2.9
—
7
240
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
11
32
3.48
3.34
1.7
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
52
310
1.74
3.32
3.7
3.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
74
1082
0.64
3.27
1.8
1.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
43
244
1.82
3.24
3.4
3.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
50
298
1.74
3.20
4.4
5.3
%
1.0
0.4
—
10
78
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
37
202
1.89
3.15
12.5
16.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
51
308
1.72
3.13
5.1
5.6
%
0.1
0.1
0.04
18
101
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
64
411
1.62
3.12
2.2
2.6
u/l
24.1
30.2
1.45
53
337
(3003888) Timothy IgE Ab [Units/volume] in Serum
13
321
0.39
3.01
1.2
1.2
u/ml
0.9
5.5
—
6
252
(3039443) Prostate specific Ag panel - Serum or Plasma
0
77
0.00
2.98
0.0
1.5
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
19
82
2.36
2.94
1.3
1.5
nmol/l
0.3
0.4
0.16
14
67
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
31
164
1.94
2.90
1.8
4.8
e6/l
43.0
6.4
0.54
25
119
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
31
164
1.94
2.90
1.8
4.9
e6/l
165.1
367.4
0.61
25
122
(40768804) Tissue Pathology biopsy report
106
1412
0.70
2.89
2.0
1.9
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
13
315
0.40
2.89
1.2
1.2
u/ml
0.3
1.1
—
6
234
(3021960) Folate [Moles/volume] in Serum or Plasma
93
663
1.48
2.86
1.6
1.4
nmol/l
20.6
21.5
0.23
83
574
(3000494) Fungus identified in Specimen by Culture
71
479
1.55
2.82
1.7
1.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
31
166
1.91
2.81
2.2
1.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
29
153
1.94
2.75
1.9
5.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
169
0.29
2.73
1.0
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
33
183
1.85
2.70
1.8
2.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
24
447
0.52
2.64
2.4
2.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
25
127
2.01
2.64
1.6
2.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
26
136
1.95
2.54
1.3
1.6
—
—
—
0
0
(3020891) Body temperature
25
129
1.98
2.54
5.1
7.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
166
1337
1.34
2.50
2.8
3.0
—
—
—
0
0
(44790048)
25
131
1.95
2.44
1.5
2.4
—
—
—
0
0
(44790049)
25
131
1.95
2.44
1.5
2.4
—
—
—
0
0
(44790047)
25
131
1.95
2.44
1.5
2.4
—
—
—
0
0
(44806118)
25
131
1.95
2.44
1.5
2.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
119
916
1.37
2.39
2.0
3.9
mg/l
1.5
1.7
0.20
98
693
(3021901) Oxygen saturation in Capillary blood
20
97
2.10
2.39
3.6
8.5
—
—
—
0
0
(3039000) Anion gap in Blood
14
58
2.45
2.38
6.7
13.5
mmol/l
12.2
11.2
0.57
14
46
(3018572) Chloride [Moles/volume] in Blood
14
58
2.45
2.38
6.7
13.5
mmol/l
105.8
105.2
0.22
14
46
(3019150) Specific gravity of Urine by Refractometry
121
936
1.37
2.36
4.9
3.3
kg/l
1.0
1.0
0.78
27
165
(3027945) Reticulocytes/100 erythrocytes in Blood
82
593
1.44
2.35
5.3
6.2
%
1.6
1.5
0.56
72
564
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
7
186
0.37
2.32
1.1
1.8
nmol/l
33.4
35.2
—
7
179
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
187
0.37
2.31
1.0
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
13
4.65
2.27
1.7
1.7
—
—
—
0
0
(3000492) Spirometry study
25
435
0.56
2.22
1.4
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
507
4797
1.41
2.19
19.5
12.2
mg/l
26.4
22.7
1.75
437
3476
(3002385) Erythrocyte distribution width [Ratio]
473
4430
1.35
2.15
24.5
16.5
%
13.7
13.3
4.13
465
4373
(3004789) Transferrin [Mass/volume] in Serum or Plasma
84
621
1.41
2.15
2.8
2.9
g/l
2.5
2.5
0.09
79
596
(3007930) Methemoglobin/Hemoglobin.total in Blood
20
102
1.99
2.12
6.6
9.8
%
1.0
0.9
0.38
20
90
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
15
68
2.24
2.12
1.3
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
16
75
2.16
2.10
2.4
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
23
124
1.89
2.09
1.8
5.9
—
—
—
0
0
(3036489) Thrombin time
47
312
1.55
2.05
2.4
7.7
s
21.8
23.3
2.31
42
296
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
31
185
1.71
2.05
1.9
2.3
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
5
145
0.34
2.04
1.8
4.8
umol/l
6.2
11.7
—
5
122
(40761511) CBC panel - Blood by Automated count
514
4888
1.41
2.03
17.3
10.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
9
32
2.84
2.00
11.7
8.6
mmol/l
0.7
0.6
—
9
32
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
50
339
1.52
1.99
7.3
5.9
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
11
4.57
1.94
1.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
11
4.57
1.94
9.0
3.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
11
4.57
1.94
9.0
3.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
21
367
0.56
1.92
2.4
2.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
217
1868
1.26
1.89
3.9
4.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
59
419
1.45
1.89
4.4
4.9
e9/l
72.3
66.6
0.67
38
280
(3044889) 12 lead EKG panel
276
2443
1.24
1.87
3.6
2.9
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
9
34
2.67
1.87
2.6
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
8
182
0.43
1.84
1.9
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
8
183
0.43
1.84
1.9
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
78
586
1.38
1.83
2.9
3.0
%
23.4
22.4
0.29
65
546
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
53
2.29
1.81
1.2
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
30
469
0.62
1.80
2.7
2.4
ug/l
0.7
0.7
0.03
22
248
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
44
631
0.67
1.77
1.3
1.2
u/ml
2.4
8.1
—
8
236
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
345
3746
0.81
1.77
4.5
3.7
mmol/l
1.3
1.4
6.85
317
3528
(3022621) pH of Urine by Test strip
35
226
1.58
1.74
4.5
1.9
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
49
0.00
1.69
0.0
1.4
—
56.3
—
0
10
(3019225) pH of Specimen
39
261
1.53
1.68
5.0
5.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
19
3.18
1.66
1.3
1.5
nmol/l
165.2
143.6
—
6
19
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
132
1086
1.28
1.66
2.6
3.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
174
1481
1.25
1.64
4.8
3.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
87
1098
0.76
1.63
1.9
2.0
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
14
70
2.02
1.60
1.3
1.9
umol/l
4.4
3.6
0.47
14
60
(3014051) Protein [Presence] in Urine by Test strip
16
85
1.91
1.56
2.0
1.7
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
20
332
0.59
1.55
1.2
1.2
—
39.7
—
0
12
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
33
2.44
1.54
1.6
1.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
37
250
1.51
1.54
1.1
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
49
667
0.71
1.50
1.3
1.2
iu/ml
8.6
29.2
—
10
183
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
37
529
0.68
1.49
1.2
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
68
874
0.75
1.45
1.9
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
21
125
1.70
1.45
1.8
2.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
86
682
1.31
1.44
2.8
2.9
umol/l
14.0
13.6
0.22
79
650
(3019977) pH of Arterial blood
5
16
3.14
1.44
9.8
6.8
—
7.4
—
0
5
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
18
104
1.75
1.38
5.4
9.7
%
1.6
1.5
0.59
18
91
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
39
0.00
1.34
0.0
2.8
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
39
0.00
1.34
0.0
5.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
68
1.93
1.34
1.3
1.6
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
32
217
1.50
1.33
13.7
14.0
mmol/l
24.1
24.1
0.04
32
208
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
0
40
0.00
1.33
0.0
9.1
—
1.8
—
0
33
(3004588) Protein electrophoresis panel - Serum or Plasma
23
145
1.61
1.30
1.3
2.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
19
114
1.69
1.29
1.1
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
45
329
1.40
1.28
3.4
2.2
e9/l
4.2
4.1
0.18
39
297
(3016018) Differential panel - Cerebral spinal fluid
17
99
1.74
1.28
1.6
4.5
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
24
362
0.65
1.28
2.1
2.3
—
14.6
—
0
16
(3037756) Immunofixation for Serum or Plasma
9
44
2.06
1.27
1.1
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
30
431
0.68
1.26
1.2
1.2
—
—
—
0
0
(4146454)
6
25
2.41
1.24
3.3
3.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
45
2.01
1.23
1.3
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
45
2.01
1.23
1.3
1.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
12
63
1.92
1.23
2.3
1.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
12
63
1.92
1.23
1.0
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
338
3617
0.84
1.23
4.0
3.5
mmol/l
1.3
1.3
0.86
308
3409
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
37
2.18
1.21
1.0
3.0
pg
33.5
31.7
—
8
37
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
23
148
1.58
1.21
2.0
2.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
55
708
0.75
1.20
1.2
1.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
41
299
1.40
1.20
2.8
9.1
g/l
2.7
2.9
0.54
41
293
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
8
38
2.12
1.18
1.0
2.8
nmol/l
2.9
3.7
—
8
33
(1002224) Polysomnography panel
11
198
0.55
1.18
1.0
1.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
0
34
0.00
1.16
0.0
6.6
—
42.8
—
0
5
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
34
0.00
1.16
0.0
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
15
87
1.74
1.16
5.3
4.3
%
54.0
52.6
0.11
15
87
(3023323) Follitropin [Units/volume] in Serum or Plasma
45
336
1.37
1.15
2.4
1.9
iu/l
19.7
16.4
0.22
31
239
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
35
0.00
1.15
0.0
8.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
38
276
1.40
1.14
1.8
1.3
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
14
80
1.77
1.13
1.4
4.4
umol/l
25.8
25.8
0.00
14
80
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
81
1.75
1.09
1.5
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
41
1.96
1.09
1.1
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
41
1.96
1.09
1.1
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
41
1.96
1.09
1.1
1.7
—
—
—
0
0
(4198724)
11
59
1.88
1.08
2.4
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
10
179
0.55
1.07
1.1
1.4
miu/ml
—
244.9
—
0
89
(4281824)
5
22
2.28
1.03
1.4
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
22
2.28
1.03
1.2
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
22
2.28
1.03
1.2
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
22
2.28
1.03
1.2
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
22
2.28
1.03
1.2
1.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
18
114
1.60
1.03
4.8
18.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
18
274
0.65
1.03
1.1
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
53
1.90
1.01
1.3
1.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
65
524
1.27
1.00
3.6
3.5
g/l
9.7
9.1
0.65
57
498
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
356
3348
1.16
0.99
16.2
9.6
ml/min/173m2
98.9
92.3
4.22
281
2543
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
11
61
1.82
0.99
1.8
2.7
ug/min
35.3
82.0
—
6
40
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
19
124
1.55
0.97
1.6
1.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
30
0.00
0.97
0.0
1.3
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
6
118
0.50
0.95
1.0
1.3
u/ml
0.8
27.0
—
6
97
(3030905) Polymorphonuclear cells [#/volume] in Blood
14
85
1.66
0.95
3.6
3.8
e9/l
3.8
3.8
0.02
14
85
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
51
1.78
0.95
1.1
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
21
302
0.68
0.93
1.0
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
15
94
1.61
0.91
1.3
1.1
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
6
29
2.08
0.89
2.7
3.4
mg/l
18.2
13.9
—
6
22
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
25
178
1.42
0.87
2.1
2.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
8
44
1.83
0.86
1.3
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
8
44
1.83
0.86
1.3
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
8
44
1.83
0.86
1.3
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
21
145
1.46
0.86
1.1
1.3
ug/g
345.2
342.0
0.03
15
84
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
31
1.94
0.84
1.5
4.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
8
45
1.79
0.84
1.4
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
19
272
0.69
0.84
1.5
1.7
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
32
1.88
0.82
3.5
2.9
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
6
32
1.88
0.82
3.5
2.9
mmol/l
105.8
105.8
—
6
32
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
352
3333
1.14
0.82
6.7
4.6
mmol/mol
40.9
38.4
2.96
325
3156
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
24
0.00
0.79
0.0
1.5
—
—
—
0
0
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.0
—
6.9
—
0
16
(3015183) Erythrocyte sedimentation rate
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
361
3783
0.88
0.78
4.4
3.8
mmol/l
4.4
4.6
5.80
336
3586
(3024980) IgG subclass 4 [Mass/volume] in Serum
7
124
0.56
0.78
1.4
1.5
g/l
0.4
0.6
—
7
108
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
13
82
1.60
0.78
6.7
5.9
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
11
174
0.62
0.78
2.7
1.7
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
0
27
0.00
0.77
0.0
1.4
—
56.0
—
0
21
(3041354) Potassium [Moles/volume] in Venous blood
6
34
1.77
0.76
3.5
2.8
mmol/l
3.9
4.0
—
6
34
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
2.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
121
1070
1.16
0.76
4.2
3.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
35
271
1.31
0.76
2.1
3.0
ml/min/173m2
87.0
75.2
0.41
12
105
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
59
1.71
0.76
1.3
1.3
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
9
53
1.71
0.75
6.6
4.2
mmol/l
7.8
6.8
—
9
53
(3045414) Leukocytes [Presence] in Urine
23
167
1.39
0.74
1.8
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
362
3786
0.88
0.74
5.0
4.0
mmol/l
2.7
2.8
2.93
333
3553
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
6
109
0.55
0.73
7.8
3.5
u/ml
34.5
51.1
—
6
104
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
25
2.01
0.73
4.0
4.6
ug/l
158.2
215.4
—
5
25
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
17
117
1.47
0.72
1.2
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
57
1.59
0.71
1.3
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
36
452
0.78
0.71
2.3
2.3
nmol/l
11.4
13.3
0.66
29
388
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
26
1.93
0.70
1.0
1.1
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
26
1.93
0.70
2.0
1.5
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
26
1.93
0.70
1.0
1.1
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
13
85
1.54
0.69
4.0
6.0
ug/l
1.3
2.4
1.81
13
85
(3000330) Specific gravity of Urine by Test strip
22
161
1.38
0.69
3.4
2.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
59
1.53
0.68
2.3
1.7
—
—
—
0
0
(3022670) pH of Venous cord blood
5
27
1.86
0.68
1.0
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
31
393
0.78
0.66
1.3
1.8
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
7
44
1.60
0.65
3.7
1.6
%
95.7
130.3
—
7
44
(40768443) Skin Pathology biopsy report
8
129
0.61
0.64
1.0
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
102
0.58
0.62
1.0
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
59
500
1.20
0.62
1.3
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
11
164
0.66
0.62
1.4
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
6
105
0.57
0.62
3.0
3.2
—
668.6
—
0
14
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
19
255
0.74
0.61
1.2
1.8
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
20
0.00
0.60
0.0
2.6
—
—
—
0
0
(4035726)
26
332
0.77
0.60
1.3
1.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
21
0.00
0.60
0.0
2.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
26
201
1.31
0.60
1.0
1.0
mu/l
10.4
8.4
0.98
26
175
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
8
52
1.54
0.59
1.4
4.1
ug/l
24.2
20.0
—
8
52
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
52
1.54
0.59
1.1
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
51
429
1.21
0.59
1.8
1.9
g/l
1.0
1.0
0.12
45
406
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
112
0.62
0.58
1.0
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
23
0.00
0.58
0.0
2.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
38
461
0.81
0.58
1.1
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
6
35
1.72
0.58
8.2
2.5
—
—
—
0
0
(4306422)
12
81
1.49
0.57
1.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
11
160
0.68
0.56
1.4
1.1
—
—
—
0
0
(4094501)
5
89
0.56
0.56
1.2
1.1
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
5
89
0.56
0.56
1.0
1.4
g/l
1.6
2.2
—
5
75
(4062490)
5
89
0.56
0.56
1.0
1.4
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
5
89
0.56
0.56
1.0
1.4
g/l
0.5
0.4
—
5
73
(3027135) IgG subclass 1 [Mass/volume] in Serum
5
89
0.56
0.56
1.0
1.4
g/l
5.9
5.8
—
5
74
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
15
205
0.72
0.55
1.1
1.1
—
11.1
—
0
5
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
152
1644
0.90
0.53
1.5
1.6
u/ml
7.0
2.6
0.62
28
338
(3028707) Methadone [Presence] in Urine by Screen method
25
196
1.29
0.53
4.5
2.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
69
603
1.16
0.53
2.6
6.1
umol/l
4.5
7.4
2.51
53
522
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
18
237
0.75
0.53
1.3
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
30
369
0.80
0.53
3.9
2.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
145
1571
0.90
0.52
1.6
1.6
g/l
1.7
1.9
0.49
85
860
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
11
157
0.69
0.52
1.5
1.6
iu/ml
0.0
0.0
—
5
38
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
23
179
1.30
0.52
1.6
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
12
168
0.71
0.51
1.5
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
19
144
1.33
0.51
3.8
2.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
32
388
0.81
0.50
3.4
1.9
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
93
1.41
0.48
1.0
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
77
862
0.88
0.48
2.3
3.0
ug/g
522.7
97.3
0.72
58
709
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
26
209
1.25
0.47
1.4
2.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
7
48
1.46
0.47
1.0
2.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
49
1.43
0.46
1.3
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
15
112
1.35
0.45
1.3
1.8
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
12
86
1.40
0.44
1.2
2.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
129
0.69
0.43
1.1
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
14
104
1.35
0.43
1.6
4.8
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
5
31
1.62
0.43
1.2
1.1
—
61.4
—
0
5
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
112
1028
1.11
0.43
1.7
1.8
mmol/l
1.4
1.4
0.23
98
907
(4268621)
8
56
1.43
0.42
3.3
2.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
91
0.66
0.42
1.2
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
12
87
1.39
0.42
1.4
1.4
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
5
32
1.57
0.42
1.2
1.0
—
84.8
—
0
5
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
32
1.57
0.42
3.4
1.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
10
70
1.44
0.42
2.3
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
77
852
0.89
0.41
2.2
3.9
umol/l
4999.3
5341.0
0.02
65
768
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
371
3597
1.08
0.41
4.8
3.5
mmol/l
6.1
5.7
3.53
341
3332
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
12
88
1.37
0.40
1.2
1.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
18
0.00
0.40
0.0
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
102
0.68
0.40
1.1
1.8
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(4034850)
15
115
1.31
0.39
13.8
10.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
67
1.35
0.38
1.4
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
41
1.47
0.36
1.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
78
0.64
0.36
2.4
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
34
394
0.85
0.36
3.6
2.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
108
1.30
0.35
2.0
1.6
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
43
1.40
0.35
1.0
1.6
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
552
5464
1.16
0.34
28.9
18.1
e9/l
7.3
6.9
1.91
538
5266
(3027008) Opiates [Presence] in Urine
34
392
0.86
0.34
3.6
2.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
69
628
1.11
0.32
2.0
1.7
%
1.5
1.4
1.13
61
572
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
74
1.36
0.32
1.8
1.5
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
47
1.28
0.32
1.2
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
47
1.28
0.32
1.2
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
34
388
0.87
0.30
3.6
2.1
—
—
—
0
0
(44813793)
7
57
1.23
0.29
1.0
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
36
317
1.14
0.29
2.6
2.0
u/l
8.8
6.6
0.45
21
205
(3026361) Erythrocytes [#/volume] in Blood
551
5461
1.14
0.28
28.9
18.1
e12/l
4.6
4.6
2.00
537
5262
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
5
74
0.67
0.26
1.0
1.0
g/l
168.0
161.3
—
5
74
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
75
0.66
0.26
1.6
2.0
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
5
75
0.66
0.26
1.0
1.3
u/ml
1.7
6.5
—
5
68
(3007461) Platelets [#/volume] in Blood
550
5454
1.13
0.25
29.1
18.1
e9/l
256.7
261.4
0.79
536
5273
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
14
114
1.23
0.25
2.1
2.0
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
9
75
1.20
0.25
1.4
1.6
g/l
40.1
38.7
—
9
70
(3021879) Hepatitis B virus core Ab [Presence] in Serum
35
391
0.89
0.24
1.5
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
284
2913
0.95
0.23
4.3
3.8
u/l
49.7
40.7
1.67
266
2787
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
38
1.32
0.23
2.0
1.9
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
91
0.77
0.22
1.1
1.2
—
1.0
—
0
6
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
95
0.73
0.22
2.1
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
22
252
0.87
0.22
1.2
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
41
1.22
0.22
1.0
1.3
nmol/l
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
51.2
—
0
10
(3047189) Immunofixation for 24 hour Urine
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
12
0.00
0.21
0.0
1.4
—
24.7
—
0
12
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
12
0.00
0.21
0.0
6.9
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
4.0
—
0.5
—
0
12
(3020650) Glucose [Presence] in Urine
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
28
249
1.13
0.21
5.6
7.8
g/l
0.3
0.3
0.02
20
185
(3020393) Adenovirus Ag [Presence] in Stool
11
89
1.24
0.21
2.5
2.2
—
—
—
0
0
(3006598) pH of Arterial cord blood
19
164
1.16
0.20
1.0
1.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
27
240
1.13
0.20
2.7
4.4
ug/l
7.2
7.4
0.02
20
180
(3024471) HLA-A [Type]
6
48
1.25
0.20
1.0
1.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
50
1.20
0.19
2.0
1.1
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
6
53
1.13
0.18
51.2
47.9
ug/l
6.4
6.6
—
6
47
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
14
119
1.18
0.17
1.3
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
11
131
0.84
0.17
1.1
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
66
0.76
0.17
1.4
1.5
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
67
0.74
0.17
1.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
68
1.18
0.16
1.0
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
69
1.16
0.16
1.1
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
8
69
1.16
0.16
2.1
1.4
e6/l
4508.8
9977.5
—
8
51
(3001122) Ferritin [Mass/volume] in Serum or Plasma
201
2062
0.96
0.16
3.3
3.2
ug/l
92.8
91.6
0.04
185
1945
(3027231) Wheat IgE Ab [Units/volume] in Serum
6
80
0.75
0.15
1.0
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
11
129
0.85
0.15
1.0
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
34
367
0.92
0.14
1.1
1.3
iu/ml
78.9
143.6
—
10
128
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
20
179
1.12
0.14
1.3
1.6
—
153.3
—
0
6
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
84
1.19
0.14
1.4
1.6
g/l
2.9
3.1
—
10
73
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
117
0.85
0.13
2.1
1.9
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
327
3226
1.03
0.11
3.6
4.2
mm/h
10.2
8.7
1.28
304
3015
(1001926) Buprenorphine [Presence] in Urine by Screen method
29
311
0.93
0.11
4.0
2.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
25
270
0.92
0.11
10.0
2.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
60
626
0.95
0.10
3.4
3.3
%
18.2
22.6
1.55
18
206
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
5
46
1.09
0.09
1.0
1.1
mg/l
205.9
208.6
—
5
41
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
21
227
0.92
0.09
3.9
2.5
u/l
1312.4
2861.8
—
7
86
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
5
48
1.04
0.09
1.0
1.3
nmol/l
0.5
0.5
—
5
43
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
61
0.82
0.08
5.0
2.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
75
0.80
0.07
1.0
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
8
74
1.08
0.07
8.1
25.5
%
12.3
12.1
—
8
74
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
13
143
0.91
0.07
1.5
2.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
8
75
1.07
0.07
2.0
2.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
28
296
0.94
0.07
1.3
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
88
1.02
0.07
1.2
1.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
89
1.13
0.06
1.4
1.6
g/l
7.6
7.3
—
10
75
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
89
1.13
0.06
1.4
1.6
g/l
3.3
3.8
—
10
71
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
89
1.13
0.06
1.4
1.6
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
9
103
0.87
0.06
1.1
1.2
—
39.4
—
0
8
(3037522) Nuclear Ab [Titer] in Serum
63
648
0.97
0.06
1.3
1.4
titre
420.0
465.2
—
8
116
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
37
356
1.04
0.05
4.4
3.7
%
29.3
31.2
0.64
26
249
(4010399)
28
269
1.04
0.04
1.4
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
65
662
0.98
0.03
1.8
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
41
400
1.03
0.02
1.5
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
37
379
0.97
0.02
1.5
1.7
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
14
146
0.96
0.01
1.1
1.2
—
2.8
—
0
10
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
13
124
1.05
0.00
3.4
4.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
14
134
1.05
0.00
1.7
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
142
1425
0.99
0.00
1.4
1.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
24
236
1.02
0.00
1.3
2.0
u/ml
212.2
193.2
0.17
11
116
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
24
241
1.00
0.00
1.3
2.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
101
1010
1.00
0.00
5.8
5.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
15
145
1.03
0.00
1.5
1.7
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3000936) Kiwifruit IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
4.2
—
0
5
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
2.0
—
9.6
—
0
5
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
0
5
0.00
0.00
0.0
1.4
—
21.4
—
0
5
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
5.8
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
79
0.88
0.00
1.9
2.7
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
63
0.95
0.00
1.3
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
9
0.00
0.00
0.0
8.3
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
55
0.91
0.00
7.0
4.3
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
68
0.88
0.00
1.0
1.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
16.6
—
0
6
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
9
0.00
0.00
0.0
11.9
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
70
1.00
0.00
6.6
2.8
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
0
7
0.00
0.00
0.0
1.7
—
346.3
—
0
7
(40765089) Chromosome analysis panel - Blood by G-banded
5
55
0.91
0.00
1.8
1.0
—
—
—
0
0
(44806071)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(4038314)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
9
0.00
0.00
0.0
17.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
68
0.88
0.00
3.0
2.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
57
0.88
0.00
2.0
1.3
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
4.5
—
3.7
—
0
6
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
7
72
0.97
0.00
1.4
2.2
—
1792.0
—
0
5
(3016135) IgD [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
27.7
—
0
7
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
5
59
0.85
0.00
2.2
4.0
—
88.3
—
0
17
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
55
0.91
0.00
7.0
4.3
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
5
57
0.88
0.00
1.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint F5_OTHRET and mortality.

Females

Parameter HR [95% CI] p-value
F5_OTHRET 5.514 [4.46, 6.81] < 0.001
Birth year 0.994 [0.98, 1.0] 0.157

During the follow-up period (1.1.1998 — 31.12.2019), 447 out of 3621 females with F5_OTHRET died.

Males

Parameter HR [95% CI] p-value
F5_OTHRET 4.418 [3.68, 5.31] < 0.001
Birth year 0.984 [0.97, 0.99] 0.003

During the follow-up period (1.1.1998 — 31.12.2019), 509 out of 5439 males with F5_OTHRET died.

Mortality risk

Mortality risk for people of age

years, who have F5_OTHRET.

N-year risk Females Males
1 0.518% 1.017%
5 2.797% 5.521%
10 7.457% 12.32%
15 14.119% 20.931%
20 23.79% 32.784%

Relationships between endpoints

↥

Index endpoint: F5_OTHRET – Other and unspecified mental retardation

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data